Date published: 2025-10-20

1-800-457-3801

SCBT Portrait Logo
Seach Input

Hinokitiol (CAS 499-44-5)

5.0(1)
Write a reviewAsk a question

Alternate Names:
4-Isopropyltropolone
Application:
Hinokitiol is an apoptosis inducer and potent metal chelator
CAS Number:
499-44-5
Purity:
≥98%
Molecular Weight:
164.2
Molecular Formula:
C10H12O2
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Hinokitiol, a natural tropolone derivative, has garnered significant attention in scientific research due to its diverse biological activities and potential applications. Studies have explaind its multifaceted mechanisms of action, including antimicrobial, anti-inflammatory, antioxidant, and anticancer properties. As an antimicrobial agent, hinokitiol exhibits broad-spectrum activity against bacteria, fungi, and viruses, disrupting microbial membranes, inhibiting enzyme activities, and interfering with nucleic acid synthesis. Additionally, hinokitiol′s anti-inflammatory effects are attributed to its ability to suppress pro-inflammatory cytokine production, inhibit nuclear factor-kappa B (NF-κB) signaling, and modulate immune cell functions. Moreover, hinokitiol demonstrates potent antioxidant activity by scavenging free radicals and enhancing endogenous antioxidant defenses, protecting cells from oxidative stress-induced damage. Furthermore, hinokitiol has emerged as a promising anticancer agent, exerting cytotoxic effects on various cancer cell types through multiple mechanisms, including induction of apoptosis, cell cycle arrest, inhibition of angiogenesis, and modulation of oncogenic signaling pathways. Its ability to target different cellular processes makes hinokitiol a valuable tool for studying microbial pathogenesis, inflammatory diseases, oxidative stress-related disorders, and cancer biology. Researchers are actively exploring hinokitiol′s potential in various preclinical models, aiming to develop novel strategies for combating infectious diseases, inflammatory disorders, and cancer, highlighting its significance in biomedical research and drug discovery endeavors.


Hinokitiol (CAS 499-44-5) References

  1. Antimicrobial activity and metalloprotease inhibition of hinokitiol-related compounds, the constituents of Thujopsis dolabrata S. and Z. hondai MAK.  |  Inamori, Y., et al. 1999. Biol Pharm Bull. 22: 990-3. PMID: 10513629
  2. Apoptosis during iron chelator-induced differentiation in F9 embryonal carcinoma cells.  |  Tanaka, T., et al. 1999. Cell Biol Int. 23: 541-50. PMID: 10704238
  3. (-)-Epigallocatechin-3-gallate and hinokitiol reduce melanin synthesis via decreased MITF production.  |  Kim, DS., et al. 2004. Arch Pharm Res. 27: 334-9. PMID: 15089040
  4. Hinokitiol, a metal chelator derived from natural plants, suppresses cell growth and disrupts androgen receptor signaling in prostate carcinoma cell lines.  |  Liu, S. and Yamauchi, H. 2006. Biochem Biophys Res Commun. 351: 26-32. PMID: 17055455
  5. In vitro antimicrobial and anticancer potential of hinokitiol against oral pathogens and oral cancer cell lines.  |  Shih, YH., et al. 2013. Microbiol Res. 168: 254-62. PMID: 23312825
  6. Hinokitiol induces autophagy in murine breast and colorectal cancer cells.  |  Wang, WK., et al. 2016. Environ Toxicol. 31: 77-84. PMID: 25044443
  7. Hinokitiol, a tropolone derivative, inhibits mouse melanoma (B16-F10) cell migration and in vivo tumor formation.  |  Huang, CH., et al. 2015. Eur J Pharmacol. 746: 148-57. PMID: 25449038
  8. Hinokitiol Inhibits Melanogenesis via AKT/mTOR Signaling in B16F10 Mouse Melanoma Cells.  |  Tsao, YT., et al. 2016. Int J Mol Sci. 17: 248. PMID: 26901194
  9. Hinokitiol-Loaded Mesoporous Calcium Silicate Nanoparticles Induce Apoptotic Cell Death through Regulation of the Function of MDR1 in Lung Adenocarcinoma Cells.  |  Shen, YF., et al. 2016. Materials (Basel). 9: PMID: 28773431
  10. Hinokitiol copper complex inhibits proteasomal deubiquitination and induces paraptosis-like cell death in human cancer cells.  |  Chen, X., et al. 2017. Eur J Pharmacol. 815: 147-155. PMID: 28887042
  11. Hinokitiol up-regulates miR-494-3p to suppress BMI1 expression and inhibits self-renewal of breast cancer stem/progenitor cells.  |  Chen, SM., et al. 2017. Oncotarget. 8: 76057-76068. PMID: 29100291
  12. Hinokitiol reduces tumor metastasis by inhibiting heparanase via extracellular signal-regulated kinase and protein kinase B pathway.  |  Wu, YJ., et al. 2020. Int J Med Sci. 17: 403-413. PMID: 32132875
  13. Hinokitiol induces cell death and inhibits epidermal growth factor-induced cell migration and signaling pathways in human cervical adenocarcinoma.  |  Wang, CC., et al. 2020. Taiwan J Obstet Gynecol. 59: 698-705. PMID: 32917321
  14. Different Cell Responses to Hinokitiol Treatment Result in Senescence or Apoptosis in Human Osteosarcoma Cell Lines.  |  Yang, SC., et al. 2022. Int J Mol Sci. 23: PMID: 35163553
  15. Inhibitory effect of beta-thujaplicin on ultraviolet B-induced apoptosis in mouse keratinocytes.  |  Baba, T., et al. 1998. J Invest Dermatol. 110: 24-8. PMID: 9424082

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Hinokitiol, 50 mg

sc-200812
50 mg
$63.00

Hinokitiol, 250 mg

sc-200812A
250 mg
$193.00

Hinokitiol, 1 g

sc-200812B
1 g
$357.00

Hinokitiol, 10 g

sc-200812C
10 g
$714.00

Hinokitiol, 50 g

sc-200812D
50 g
$1533.00

Hinokitiol, 100 g

sc-200812E
100 g
$2244.00